Natera, Inc. (NTRA)

207.78 -0.62 (-0.30%) USD  |  NASDAQ  |  Apr 20, 16:00
207.66 -0.12 (-0.06%) After-Hours: 19:33
More

Natera SG&A Expense (Quarterly) : 291.30M for Dec. 31, 2025

SG&A Expense (Quarterly) Chart

View SG&A Expense (Quarterly) for NTRA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

SG&A Expense (Quarterly) Range, Past 5 Years

View SG&A Expense (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (Quarterly) Benchmarks

View SG&A Expense (Quarterly) Benchmarks
Start Trial
Illumina, Inc. 310.00M
GeneDx Holdings Corp. 73.96M
Delcath Systems, Inc. 10.53M
CytoSorbents Corp. 9.612M
Odyssey Health, Inc. 0.1819M